GeoVax Labs, Inc. New

Go to GeoVax Labs, Inc. New Website

$0.75

0.03 (3.49%)
Live
Previous Close

$0.7247

Day Range

$0.7105 - $0.776

Previous Day Range

$0.688 - $0.7439

Market Cap

$18.4 million USD

Day Vol.

469491

Previous Day Vol.

538396

Currency

USD

Primary Exchange

Nasdaq

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical t...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Several biotech companies are advancing cancer research with promising clinical milestones, focusing on innovative immunotherapies and targeted treatments amid rising cancer incidence and potential research funding challenges.

Related tickers: ONCY, ZLAB, GOVX, GOVXW, OSTX, SLS.

Read Full Article

EmergingGrowth.com announced the schedule for its 84th conference featuring presentations from multiple public companies across technology, biotech, and other sectors on July 16-17, 2025.

Related tickers: FUFU, FUFUW, FFAI, FFAIW, ADVM, GOVX, GOVXW, SRFM.

Read Full Article
Trending Tickers

Please sign in to view